Exhibit 23.1
Consent of Independent Registered Public Accounting Firm
Axonics Modulation Technologies, Inc.
Irvine, California
We hereby consent to the use in the prospectus constituting a part of this registration statement of our report dated October 5, 2018, except for Note 12, as to which the date is October 22, 2018, relating to the consolidated financial statements of Axonics Modulation Technologies, Inc., which is contained in that prospectus.
We also consent to the reference to us under the caption “Experts” in the prospectus.
/s/ BDO USA, LLP
Costa Mesa, California
October 22, 2018